Mind Over Matter: Considerations for Cannabinoid Clinical Trials – Regulatory Considerations & Designs to Minimize Placebo Effects
Time: 1:30 pm
day: Day Two
Details:
- Discussing “The Sativex Experience” – Randomized double-blind placebo controlled trials versus enriched designs
- Variables effecting cannabinoid clinical trials: patient population, background medication, rescue medication and beyond
- The medical cannabis conundrum – life beyond THC and CBD
- What’s next?
